PETER A. THOMPSON

Profile

First Name

: PETER

Middle Name

: A.

Last Name

: THOMPSON

Related Companies
Titles
Company Name
Related People
DIRECTOR
RESPONSE BIOMEDICAL CORP
WILLIAM J. ADAMS, RICHARD BASTIANI, RICHARD J. BASTIANI, RICHARD BEAR, RICHARD K. BEAR, PAUL HARRIS, ANTHONY HOLLER, ANTHONY F. HOLLER, DR. ANTHONY F. HOLLER, LIVLEEN KALER, S. WAYNE KAY, DR. JOSEPH D. KEEGAN, JOSEPH D. KEEGAN, DUANE A. MORRIS, TODD PATRICK, TODD R. PATRICK, JEFFREY L. PURVIN, CLINT SEVERSON, CLINTON H. SEVERSON, LEWIS SHUSTER, LEWIS J. SHUSTER, DR. PETER A. THOMPSON, PETER THOMPSON, ANASTASIOS TSONIS, DAVID WANG, DR. DAVID WANG, JONATHAN WANG, IAN A. WEBB
EXECUTIVE OFFICER, DIRECTOR
SILVERBACK THERAPEUTICS, INC.
VICKIE L. CAPPS, ROBERT HERSHBERG, SAQIB ISLAM, SCOTT PLATSHON, JONATHAN ROOT, THILO SCHROEDER, LAURA SHAWVER, PETER THOMPSON
DIRECTOR
DECIBEL THERAPEUTICS, INC.
TROY BRENNAN, ROGER BROWN, JENS ECKSTEIN, NEIL EXTER, STEVEN H. HOLTZMAN, JEFFREY JONAS, JOHN J. KEILTY, ELISABETH LEIDERMAN, CRAIG MUIR, ANTHONY PHILIPPAKIS, CHRISTINE A. POON, LAURENCE REID, GEORGE SCANGOS, MICHAEL SOLOMON, KEVIN STARR
DIRECTOR
RECODE THERAPEUTICS, INC.
RANA AL-HALLAQ, ALAN COLOWICK, RAKHSHITA DHAR, JULIA EASTLAND, KOUKI HARASAKI, EDWARD HURWITZ, ARTHUR E JOHNSON, HELEN KIM, HELEN S. KIM, DAVID LOCKHART, DAVID J LOCKHART, DAVID J. LOCKHART, PATRICIA MILLICAN, TRISHA MILLICAN, DEAN MITCHELL, OLEG NODELMAN, INAI PARK, RA SESSION II, SHEHNAAZ SULIMAN, PETER THOMPSON, MICHAEL TORRES, BASHEER ZADA
EXECUTIVE OFFICER
ORBIMED NEW HORIZONS FUND, L.P.
DAVID P. BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, W. CARTER NEILD, - ORBIMED ADVISORS LLC, - ORBIMED NEW HORIZONS GP LLC, MATTHEW S. RIZZO, JONATHAN T. SILVERSTEIN, C. SCOTLAND STEVENS
EXECUTIVE OFFICER
ORBIMED PARTNERS II, L.P.
DAVID BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, SAMUEL D. ISALY, SAMUEL DAVID ISALY, W. CARTER NEILD, - ORBIMED ADVISORS LLC, MATTHEW S. RIZZO, MICHAEL B. SHEFFERY, JONATHAN T. SILVERSTEIN, C. SCOTLAND STEVENS
EXECUTIVE OFFICER
ORBIMED GENESIS FUND, L.P.
MONA ASHIYA, DAVID P. BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, W. CARTER NEILD, - ORBIMED ADVISORS LLC, - ORBIMED GENESIS GP LLC, MATTHEW S. RIZZO, JONATHAN T. SILVERSTEIN, C. SCOTLAND STEVENS
EXECUTIVE OFFICER
ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
DAVID P. BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, W. CARTER NEILD, N/A ORBIMED ADVISORS LLC, N/A ORBIMED ROF IV LLC, MATTHEW S. RIZZO, C. SCOTLAND STEVENS
EXECUTIVE OFFICER
ORBIMED RCO IV OFFSHORE FEEDER, LP
DAVID P. BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, W. CARTER NEILD, N/A ORBIMED ADVISORS LLC, N/A ORBIMED ROF IV LLC, MATTHEW S. RIZZO, C. SCOTLAND STEVENS
EXECUTIVE OFFICER
ORBIMED PRIVATE INVESTMENTS IX, LP
DAVID P. BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, W. CARTER NEILD, N/A ORBIMED ADVISORS LLC, N/A ORBIMED CAPITAL GP IX LLC, MATTHEW S. RIZZO, C. SCOTLAND STEVENS
EXECUTIVE OFFICER
ORBIMED RCO V OFFSHORE FEEDER, LP
DAVID P. BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, W. CARTER NEILD, N/A ORBIMED ADVISORS LLC, N/A ORBIMED ROF V LLC, N/A ORBIMED ROF V, LP, MATTHEW S. RIZZO, C. SCOTLAND STEVENS
EXECUTIVE OFFICER
ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
DAVID P. BONITA, SVEN H. BORHO, CARL L. GORDON, GEOFFREY C. HSU, W. CARTER NEILD, N/A ORBIMED ADVISORS LLC, N/A ORBIMED ROF V LLC, N/A ORBIMED ROF V, LP, MATTHEW S. RIZZO, C. SCOTLAND STEVENS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-05
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-11-07 
2025-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-09-23 
2025-07-10
D/A
Link
HEDGE FUND 
 
 
Equity 
1998-06-01 
2025-05-06
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2024-11-15 
2025-05-06
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2024-11-15 
2024-12-06
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-11-07 
2024-07-12
D/A
Link
HEDGE FUND 
 
 
Equity 
1998-06-01 
2023-12-08
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-11-07 
2023-09-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2023-07-12
D/A
Link
HEDGE FUND 
 
 
Equity 
1998-06-01 
2023-04-28
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2022-04-29 
2023-04-14
D/A
Link
HEDGE FUND 
 
 
Equity 
2020-04-01 
2023-01-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-10-13 
2022-12-16
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2022-04-29 
2022-12-16
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2022-07-15 
2022-12-09
D/A
Link
HEDGE FUND 
 
 
Equity 
2019-11-07 
2022-07-14
D/A
Link
HEDGE FUND 
 
 
Equity 
1998-06-01 
2022-07-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2022-04-14
D/A
Link
HEDGE FUND 
 
 
Equity 
2020-04-01 
2021-10-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2020-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-02 
2020-10-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-09-22 
2018-09-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-05 
2018-01-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2017-12-22 
2017-02-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-01 
2016-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-01 
2016-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2013-10-15
D
Link
OTHER HEALTH CARE 
SERVICES-TESTING LABORATORIES [8734] 
DECLINE TO DISCLOSE 
Equity 
2013-09-26